Expression of Opioid Receptors in Osteoblast-Like MG-63 Cells, and Effects of Different Opioid Agonists on Alkaline Phosphatase and Osteocalcin Secretion by These Cells
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
We have previously shown that several stressful situations associated with tissue injury determine a decrease in serum osteocalcin concentration. Since reduced osteocalcin production is a marker of decreased osteoblastic activity, this finding could be related to the pathogenesis of osteoporosis secondary to some diseases. Endogenous opioids are involved in stress response. Proenkephalin-derived peptides have been shown to inhibit alkaline phosphatase activity, another marker of bone formation, in the murine cell line ROS-17/2.8. On the other hand, serum osteocalcin has been reported as being low in heroin abusers. We have therefore thought it of interest to study the presence of opioid receptors in the human osteoblast-like cell line MG-63, and to evaluate the effects of different opioid agonists on the secretion of alkaline phosphatase and osteocalcin by these cells. The presence of opioid receptors was studied by means of RT-PCR and immunohistochemistry. RT-PCR studies suggested the presence of specific mRNA for the three types of receptors, and immunohistochemistry clearly showed their occurrence. Osteocalcin synthesis was significantly inhibited by high concentrations of the mu agonists morphine and (D-Ala 2,N-MePhe 4,Gly 5-ol)-enkephalin although no changes were seen with the delta agonist (D-Ala 2,D-leu 5)-enkephalin. Morphine-induced osteocalcin inhibition was abolished when osteoblastic cells were incubated simultaneously with naloxone, whereas it was potentiated when cells were preincubated with naloxone. None of the opioid agonists modified the secretion of alkaline phosphatase. In conclusion, human osteoblast-like cells MG-63 express the three types of opioid receptors. Endogenous opioids may be involved in the reduction of osteocalcin observed in stressful situations associated with tissue injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pivotal experiments from two decades ago confirmed the expression of three types of opioid receptors, namely MOR, delta-opioid receptors, and kappa-opioid receptors in the human osteoblast-like cell line MG-63 via reverse transcription-polymerase chain reaction and immunohistochemistry (208).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
In the citing paper
“Data deriving from in vitro experiments on animal and human cells, as well as in animal models indicate that opioids can reduce BMD by directly influencing osteoblast activity (205-210).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
In the citing paper
“Treatment with high concentrations of the MOR agonist morphine significantly inhibited the expression of osteocalcin, a marker of osteoblast activity, without influencing the secretion of alkaline phosphatase (208).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
In the citing paper
“In addition, treatment with the opioid antagonist naloxone reversed the effect of morphine with regards to osteocalcin expression (208).”
From Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement (2024) · cites this paper as [208]
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Hsu, S. M., Raine, L., & Fanger, H. (1981) · Journal of Histochemistry & Cytochemistry · doi:10.1177/29.4.6166661 · Cited by 14,140
Stress hormones: their interaction and regulation
Axelrod, J., & Reisine, T. D. (1984) · Science · doi:10.1126/science.6143403 · Cited by 1,527
A potent and selective endogenous agonist for the µ-opiate receptor
Zadina, J. E., Hackler, L., Ge, L.-J., & Kastin, A. J. (1997) · Nature · doi:10.1038/386499a0 · Cited by 1,311
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
Mansour, A., Fox, C. A., Akil, H., & Watson, S. J. (1995) · Trends in Neurosciences · doi:10.1016/0166-2236(95)93946-u · Cited by 1,292
Endogenous Opioids: Biology and Function
Akil, H., Watson, S. J., Young, E., Lewis, M. E., Khachaturian, H., & Walker, J. M. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.07.030184.001255 · Cited by 1,224
Kieffer, B. L., Befort, K., Gaveriaux-Ruff, C., & Hirth, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12048 · Cited by 1,010
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., & Bell, G. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6736 · Cited by 618
A brief history of opiates, opioid peptides, and opioid receptors.
Brownstein, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5391 · Cited by 491
Neural substrates of opiate withdrawal
Koob, G. F., Maldonado, R., & Stinus, L. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90171-4 · Cited by 359
An opiate-receptor gene family reunion
Uhl, G. R., Childers, S., & Pasternak, G. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90110-4 · Cited by 286
Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene.
Min, B. H., Augustin, L. B., Felsheim, R. F., Fuchs, J. A., & Loh, H. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9081 · Cited by 169
MAJESKA, R. J., NAIR, B. C., & RODAN, G. A. (1985) · Endocrinology · doi:10.1210/endo-116-1-170 · Cited by 162
Isolation of a Human κ Opioid Receptor cDNA from Placenta
Mansson, E., Bare, L. A., & Yang, D. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2091 · Cited by 121
δ-Opioid Receptor Gene Expression in Lymphocytes
Chuang, L. F., Chuang, T. K., Killam, K. F., Chuang, A. J., Kung, H., Yu, L., & Chuang, R. Y. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2071 · Cited by 118
Vyberg, M., & Nielsen, S. (1998) · Applied Immunohistochemistry · doi:10.1097/00022744-199803000-00002 · Cited by 102
Jin, D. F., Muffly, K. E., Okulicz, W. C., & Kilpatrick, D. L. (1988) · Endocrinology · doi:10.1210/endo-122-4-1466 · Cited by 82
Zadina, J. E., Harrison, L. M., Ge, L.-J., Kastin, A. J., & Chang, S. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22512-5 · Cited by 68
Imura, H., Kato, Y., Nakai, Y., Nakao, K., Tanaka, I., Jingami, H., Koh, T., Yoshimasa, T., Tsukada, T., Suda, M., et al. (1985) · Journal of Endocrinology · doi:10.1677/joe.0.1070147 · Cited by 59
Baumhaker, Y., Gafni, M., Keren, O., & Sarne, Y. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13206-9 · Cited by 47
Stress decreases the serum level of osteocalcin
Napal, J. J., Amado, J. A., Riancho, J. A., Olmos, J. M., & González-Macı́as, J. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80013-x · Cited by 47
Self-citationMethionine-Enkephalin in Bone and Joint Tissues
Elhassan, A. M., Lindgren, J. U., Hultenby, K., Bergstrom, J., & Adem, A. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.88 · Cited by 40
(1990) · PubMed · Cited by 40
Proenkephalin A in bone-derived cells.
Rosen, H., Polakiewicz, R. D., Ben-Zakine, S., & Bar‐Shavit, Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3705 · Cited by 38
Developmental regulation of proenkephalin gene expression in osteoblasts
Rosen, H., Krichevsky, A. M., Polakiewicz, R. D., Ben-Zakine, S., & Bar‐Shavit, Z. (1995) · Molecular Endocrinology · doi:10.1210/mend.9.11.8584038 · Cited by 38
Dual role of osteoblastic proenkephalin derived peptides in skeletal tissues
Rosen, H., & Bar‐Shavit, Z. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550310 · Cited by 33
Characterization of [3H]morphine binding to interleukin-1-activated thymocytes.
Roy, S., Ge, B. L., Loh, H. H., & Lee, N. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10370-4 · Cited by 29
The Enkephalinergic Osteoblast
Rosen, H., Krichevsky, A., & Bar-Shavit, Z. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.10.1515 · Cited by 28
Differential Effects of Opioids on the Proliferation of a Macrophage Cell Line, Bac 1.2F5
Roy, S., Sedqi, M., Ramakrishnan, S., Barke, R. A., & Loh, H. H. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0118 · Cited by 28
μ-Opioid receptor binding in intact SH-SY5Y neuroblastoma cells
Toll, L. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90530-j · Cited by 18
Opioid Peptide Genes: Structure and Regulation
Höllt, V. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_2 · Cited by 12
Janicki, P., Erskine, R., & van der Watt, M. L. (1993) · Hormone and Metabolic Research · doi:10.1055/s-2007-1002061 · Cited by 11
Endogenous Opioids: Biology and Function
Akil, H. (1984) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.7.1.223 · Cited by 8
Simon, E. J. (1991) · Springer eBooks · doi:10.1007/978-3-642-46660-1_4 · Cited by 6
RT-PCR DETECTION OF OPIOID RECEPTOR mRNA IN DIFFERENT TISSUES
Barrallo, A., González‐Sarmiento, R., Santos, M. V., & Rodríguez, R. E. (1995) · Analgesia · doi:10.3727/107156995819563744 · Cited by 3
Self-citation
Research works printed but not linked: 1
- 10.1006/abio.1987.9999 · doi:10.1006/abio.1987.9999 · Paper page
Cited by
Clinical Practice Guidelines for Pain Management in Acute Musculoskeletal Injury
Hsu, J. R., Mir, H., Wally, M. K., Seymour, R. B., & the Orthopaedic Trauma Association Musculoskeletal Pain Task Force (2019) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000001430 · Cited by 280
Bone mineral density in subjects using central nervous system-active medications
Kinjo, M., Setoguchi, S., Schneeweiss, S., & Solomon, D. H. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.033 · Cited by 191
The Effect of Opioid Therapy on Endocrine Function
Brennan, M. J. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.12.001 · Cited by 166
Low bone density in patients receiving methadone maintenance treatment
Kim, T. W., Alford, D. P., Malabanan, A., Holick, M. F., & Samet, J. H. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.05.027 · Cited by 131
Vaccarino, A. L., & Kastin, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00566-6 · Cited by 88
Metadata
- Authors
- Pérez-Castrillón, J. L., Olmos, J. M., Gómez, J. J., Barrallo, A., Riancho, J. A., Perera, L., Valero, C., Amado, J. A., & González-Macías, J.
- Affiliations
- Universidad de Cantabria (ES)
- Universidad de Salamanca (ES)
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 2000
- Volume
- 72
- Issue
- 3
- Pages
- 187-194
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W2012186884
- Semantic Scholar
- 9d98b4bb3faf293a1ac066dbb2a48d51917f7482
- Cited by
- 99
- References
- 34
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 1 · 2022: 5 · 2021: 8 · 2020: 6 · 2019: 9 · 2018: 5 · 2017: 1 · 2016: 5 · 2015: 5 · 2014: 4 · 2013: 3 · 2012: 4
- FWCI
- 0.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Neuroendocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society for Bone and Mineral Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- opioid receptors, osteoblast-like cells, MG-63 cells, osteocalcin secretion, alkaline phosphatase, morphine, enkephalin, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, naloxone, endogenous opioids, stress response, bone formation, osteoporosis
- MeSH terms
- Alkaline Phosphatase, Cell Survival, Cells, Cultured, Humans, Levallorphan, Morphine, Opioid-Related Disorders, Neurons, Osteoblasts, Receptors, Opioid, RNA, Messenger, Spinal Cord, Steroid Hydroxylases, Stress, Physiological, Vitamin D, Osteocalcin, Opioid Peptides
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.